louisiana semaglutide digestive blockage law office firm gastrointestinal obstruction attorney in Ozempic Lawsuit [May 2026 Update] louisiana semaglutide digestive blockage law – glp-1 digestive blockage legal team

Wysock said her compounded tirzepatide has enabled her to continue to lose weight, to maintain a healthier lifestyle and to be present for her family and students

A landmark 2023 study published in JAMA found that GLP-1 agonist users experienced increased risks of gastrointestinal adverse events (with gastroparesis risk elevated compared to patients using other diabetes medications), while a 2024 case report in PMC documented the strong relationship between semaglutide use and gastroparesis symptoms that resolved only after drug discontinuation

Many people living with diabetes also have overweight or obesity and higher risks of kidney [archived link] or heart disease [archived link]

Parallel evolutionary pathways for glutathione transferases: Structure and mechanism of the mitochon-drial class kappa enzyme rGSTK1-1